metabolic-research
Research Use OnlyRetatrutide
Retatrutide is a synthetic peptide characterized in pre-clinical and clinical literature as a triple agonist at the GIP, GLP-1, and glucagon receptors. Investigated for its multi-receptor incretin and glucagon signaling action. Sold for laboratory research and identification purposes only. Not for human consumption.
Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Subscribe & save: $216
Quantity
Add 1 more to save 10% per unit
Technical Data
Specifications
Technical Details
Bulk Pricing
Volume Pricing Guide
Quality Assurance
Certificate of Analysis
Certificate of Analysis
COA documentation is being prepared for this product.
Contact research@roehn.co for batch-specific testing data.
Research Overview
About Retatrutide
Retatrutide (LY3437943) is a synthetic peptide engineered to simultaneously engage three metabolic receptor systems: GIP, GLP-1, and glucagon. The addition of glucagon receptor agonism to the dual-incretin framework introduces thermogenic and lipolytic mechanisms — glucagon signaling drives hepatic fat oxidation, increases energy expenditure, and promotes glycogenolysis — potentially amplifying weight reduction beyond what dual agonists achieve.
The tripartite mechanism is designed for complementary metabolic coverage: GLP-1 agonism suppresses appetite and slows gastric transit; GIP agonism modulates adipose metabolism and enhances insulin sensitivity; glucagon agonism increases basal energy expenditure and accelerates hepatic lipid clearance. Phase 2 clinical data have reported mean body weight reductions of 17–24% at higher doses, the largest treatment effects documented for any single pharmacological agent in obesity research.
ROEHN provides retatrutide at 99% HPLC-verified purity. As one of the most significant emerging compounds in metabolic peptide science, it is under active investigation for applications spanning metabolic-associated steatohepatitis (MASH), cardiovascular risk reduction, and preservation of lean mass during weight loss protocols.
